OCGN has been a great swing trade after buying bad news. The good news has replaced the
bad. Earnings are in three days. Price well below ATH. November earnings were a beat
meaning this risky Med Tech penny stock had a lower cash burn than projected. Now
legal costs will disappear. Going long with a decent position expecting a better earnings.
In law, the...
